Building on the success of hunter education courses in Texas and experience in other states, fellow Sandra McKay and other Texas physicians explain how mandatory firearm safety courses and waiting periods for young firearm buyers could reduce gun violence.
Ryan Sorensen, Richard Bui, Jade Evenstad, Bolatito Adeyeri, Sarah Kim, Emily Wang, Joyce Tiong, Usman Baig, Sandra McKayMarch 29, 2023
This brief demonstrates that the stories and voices of people on the move should be noticed and reflected, and that people on the move should have a leading say regarding the contexts and conditions that affect them, as well as how they are represented.
Migration can expose women and girls to sexual and gender-based violence (SGBV) in countries of transit and destination. SGBV has several repercussions on the physical, psychosocial, and economic well-being of those who experience it. In addition, migrant women can also experience significant sexual and reproductive health (SRH) problems due to inadequate access to care, harsh circumstances during their migratory journey, stigma, lack of information on support services, and lack of coordination between civil society and institutional structures.
Ambassador Edward P. Djerejian, director of the Baker Institute, makes the case for a comprehensive North American strategy in which the U.S., Mexico and Canada act in concert to become the global superpower of the 21st century.
Ambassador Edward P. Djerejian, director of the Baker Institute, describes the key elements of a coherent strategy for defeating ISIS, incorporating both nearer-term strategies and long-term approaches.
The Nov. 13 terrorist attacks in Paris demonstrated a change in strategy by the Islamic State — a willingness to strike outside of the Middle East. But this also yields an opportunity for a U.S.-led coalition to come together to defeat a common enemy, writes Baker Institute director Ambassador Edward P. Djerejian.
The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.
Kirstin R.W. Matthews, Monica M. MatsumotoOctober 6, 2014